Live data from Hacker News

EpiPen Price Rise Sparks Concern for Allergy Sufferers

well.blogs.nytimes.com

1–10 of 367 posts

Re: EpiPen Price Rise Sparks Concern for Allergy Sufferers

#6

Why haven't competitors entered the market with cheaper products?

because you're all cowards, and the justice department takes money from the companies who are leveraging a medical survival need to generate profits for a private company who built themselves on grants and research paid with public money.

Re: EpiPen Price Rise Sparks Concern for Allergy Sufferers

#8

Why haven't competitors entered the market with cheaper products?

> Last year, the drug maker Sanofi recalled a competing product, Auvi-Q, because it may not have been delivering the correct amount of epinephrine, leaving the EpiPen as the primary emergency treatment for severe allergic reactions.
Post reply on HN